Ambulatory pressure monitoring in the assessment of antihypertensive therapy

Cardiovascular Drugs and Therapy
A CoatsP Sleight

Abstract

A low-cost, ambulatory blood-pressure monitor has been calibrated and validated against a random zero sphygmomanometer. The repeatability of ambulatory pressure recordings after a placebo month in 44 mild to moderate untreated hypertensives was assessed. Systolic blood pressure showed a mean difference over 1 month of 2.0 mmHg, with a standard deviation of differences of 9.3 mmHg. The diastolic blood pressure mean difference was 0.1 mmHg (SD = 6.3 mmHg). This variability was much less than for clinic readings (SD = 17.3 mmHg) or for single home pressure readings (SD = 19.7 mmHg). Using ambulatory monitoring to detect a drop in pressure of 8/5 mmHg with a power of 0.9, the number of subjects needed in a parallel group trial is reduced from 360 to 68, and in a crossover study from 88 to 16 subjects. The usefulness of ambulatory pressure monitoring is demonstrated in a placebo-controlled comparison of atenolol, nifedipine retard, or their combination in random order. Eleven subjects, 21-60 years, with initial average blood pressures of 166.5/104.7 mmHg, showed a reduction in pressure with atenolol 50 mg a day of 15.1/10.0 mmHg, with nifedipine retard 20 mg b.i.d. of 21.0/11.6 mmHg, and with atenolol 50 mg and nifedipine retard 20 ...Continue Reading

References

Jul 1, 1979·British Journal of Clinical Pharmacology·M Hills, P Armitage
Jan 1, 1986·Clinical and Experimental Hypertension. Part A, Theory and Practice·J Conway
Jan 11, 1985·JAMA : the Journal of the American Medical Association·M D SchallerH R Brunner
Mar 1, 1985·Hypertension·P Sleight
Sep 1, 1985·Journal of Epidemiology and Community Health·J E GallacherP Sweetnam
Oct 1, 1969·Cardiovascular Research·J D BristowP Sleight
Apr 1, 1968·Cardiovascular Research·E B Raftery, A P Ward
Mar 1, 1984·Journal of Cardiovascular Pharmacology·B Jacot-des-CombesJ Biollaz
May 1, 1983·Archives of Internal Medicine·J I DrayerD D Brewer
Aug 1, 1982·British Journal of Clinical Pharmacology·S FreestoneL E Ramsay
Nov 15, 1980·British Medical Journal·D G Altman
May 1, 1954·A.M.A. Archives of Internal Medicine·R D TAYLORI H PAGE
Oct 13, 1951·Journal of the American Medical Association

❮ Previous
Next ❯

Citations

Jun 1, 1994·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·R J Portman, R J Yetman
Mar 23, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Robert J WeissYuhua Lin
Jul 29, 2008·Archives of Gerontology and Geriatrics·S Di MauroG Torrisi
Sep 18, 2004·Archives of Gerontology and Geriatrics·G TorrisiS Di Mauro
Jul 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·K W HansenM M Pedersen
Aug 15, 1996·Annals of the New York Academy of Sciences·L BieniaszewskiR Fagard
Nov 16, 1991·BMJ : British Medical Journal·T M MacDonaldJ C Petrie
Aug 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·M S DetollenaereD L Clement
Dec 1, 1996·American Heart Journal·L BienenfeldS P Glasser
Jul 1, 1996·Angiology·F A Prattichizzo, F Galetta
Oct 31, 2002·Clinical Pediatrics·Ari M SimckesUri S Alon
May 29, 2004·Journal of Hypertension·Marinel CavelaarsAnton H van den Meiracker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.